跳至主要内容
临床试验/IRCT20210505051188N1
IRCT20210505051188N1招募中3 期

Effect of ginger in control of nausea and vomiting in cancer patients receiving doxorubicin and platinum based chemotherapy

Ahvaz University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age over 18 years
  • Prescribing chemotherapy regimen based on doxorubicin and platinum compounds by the oncologist
  • Ability to swallow capsules
  • Having chemotherapy experience with nausea and vomiting
  • Presence in the ward for 24 hours to evaluate anti-nausea drugs
  • No history of nausea and vomiting for reasons other than chemotherapy
  • Not receiving anti-nausea and vomiting drugs in the last 24 hours

排除标准

  • Patients who do not sign the moral consent form.
  • Patients who do not cooperate during treatment for any reason to continue treatment.
  • History of any allergy to ginger
  • Occurrence of nausea before chemotherapy for any reason
  • Having any disease that causes nausea and vomiting, such as hepatitis, gastrointestinal obstruction
  • Taking anticoagulants such as heparin
  • The presence of blood disorders such as platelets less than 10,000 per microliter.

研究者

相似试验